Arş. Gör. VENHAR ÇINAR

Yayın Ağı

Makaleler 13

1. Design, Synthesis, Biological Evaluation, and Molecular Modeling Studies of Novel 2-Aminothiazole Derivatives as Potential FOXM1 Inhibitors for Triple-Negative Breast Cancer Therapy and Structure-Activity Relationship

Abusharkh K. A. N., ÇINAR V., Onder A., Sıkık M., Mustafa G., HAMURCU Z., et al.

Drug Development Research , cilt.87, sa.3, 2026 (SCI-Expanded, Scopus)

2. miR-484 as an "OncomiR" in Breast Cancer Promotes Tumorigenesis by Suppressing Apoptosis Genes

Tahtasakal R., HAMURCU Z., ÖZ A. B., Balli M., Dana H., GÖK M., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.32, sa.4, ss.2994-3008, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

3. Enhanced In Vitro and In Vivo Autophagy Suppression via LC3 siRNA-Loaded “Smart” Nanoparticles and Doxorubicin Combination Therapy in Triple Negative Breast Cancer

Walweel N., ÇINAR V., Mersin O., MACİT S., Yildiz U., Demirel E., et al.

ACS Applied Bio Materials , 2025 (ESCI, Scopus)

4. Novel benzothiazole/benzothiazole thiazolidine-2,4-dione derivatives as potential FOXM1 inhibitors: In silico, synthesis, and in vitro studies

Abusharkh K. A. N., Onder F. C., ÇINAR V., Onder A., Sikik M., HAMURCU Z., et al.

ARCHIV DER PHARMAZIE , cilt.357, sa.12, 2024 (SCI-Expanded, Scopus)

5. A drug repurposing study identifies novel FOXM1 inhibitors with in vitro activity against breast cancer cells

Abusharkh K. A. N., Onder F. C., ÇINAR V., HAMURCU Z., Ozpolat B., AY M.

MEDICAL ONCOLOGY , cilt.41, sa.8, 2024 (SCI-Expanded, Scopus)

6. LC3 siRNA-Mediated Impressed Autophagy in GBM Cells Enhances the Efficacy of Temozolomide: Inhibits Proliferation, Clone Formation and Migration of U87-MG Cells

GÖKÇEK Ö. C., ULUTABANCA H., Guler A., ÇINAR V., Nurdinov N., Kokcu N. D., et al.

MEDICINA BALEAR , cilt.39, sa.3, 2024 (ESCI)

7. The Use of Conjugated Gold Nanorods with Reduced Toxicity in Photothermal Therapy for MRSA

Yusufbeyoglu S., ÇINAR V., Ildiz N., HAMURCU Z., ÖÇSOY İ., Kilic A. B.

CHEMISTRYSELECT , cilt.9, sa.11, 2024 (SCI-Expanded, Scopus)

8. Flavopiridol Suppresses Cell Proliferation and Migration and Induces Apoptotic Cell Death by Inhibiting Oncogenic FOXM1 Signaling in IDH Wild-Type and IDH-Mutant GBM Cells

Guler A., HAMURCU Z., ULUTABANCA H., ÇINAR V., Nurdinov N., Erdem S., et al.

Molecular Neurobiology , cilt.61, sa.2, ss.1061-1079, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

9. Ganoderma lucidum Fruiting Body Dry Extract, meme kanseri hücre proliferasyonunu inhibe eder ve hem kaspaz-8 hem de kaspaz-9u aktive ederek apoptozu indükler.

GÖKTEPE Ö., ÇINAR V., HAMURCU Z., YAKAN B.

Sakarya Tıp Dergisi , cilt.13, ss.431-439, 2023 (TRDizin)

10. Ganoderma lucidum inhibits proliferation and promotes autophagy in breast cancer cell lines with varying hormonal sensitivity by regulating Beclin-1, LC3, and p62

Göktepe Ö., Önder G. Ö., Bolat D., Çınar V., Hamurcu Z., Yakan B., et al.

CUKUROVA MEDICAL JOURNAL , cilt.47, 2022 (ESCI, TRDizin)

11. The Role of Apoptosis and Autophagy in the Hypothalamic-Pituitary-Adrenal (HPA) Axis after Traumatic Brain Injury (TBI)

Taheri S., Karaca Z. C., Mehmetbeyoglu E., Hamurcu Z., Yilmaz Z., Dal F., et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , cilt.23, sa.24, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

12. Serotonin 5-HT7 receptor is a biomarker poor prognostic factor and induces proliferation of triple-negative breast cancer cells through FOXM1

ÇINAR V., HAMURCU Z., Guler A., Nurdinov N., Ozpolat B.

BREAST CANCER , cilt.29, sa.6, ss.1106-1120, 2022 (SCI-Expanded, Scopus)

13. LC3 and Beclin-1 as Markers of Autophagic Activity in Breast Cancer

Nurdinov N., ÇINAR V., Guler A., Yilmaz S. G., Kokcu N. D., HAMURCU Z.

ERCIYES MEDICAL JOURNAL , cilt.43, sa.4, ss.325-328, 2021 (ESCI, TRDizin) Sürdürülebilir Kalkınma

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler